Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Flanagan

Showing results (401-410 of 459) with videos related to

Pageof 46
Sort By:
Journal of Endocrinological Investigation|March 9, 2024
Adipokine secretion and lipolysis following gender-affirming treatment in transgender individualsN Subramanian, A Wiik, E Rullman, et al.
Journal of Immunological Methods|November 17, 2009
Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonistT Wisniewski, E Bayne, J Flanagan, et al.
Human Mutation|May 21, 2011
A pharmacogenetic approach to identify mutant forms of α-galactosidase A that respond to a pharmacological chaperone for Fabry diseaseXiaoyang Wu, Evan Katz, Maria Cecilia Della Valle, et al.
Beilstein Journal of Organic Chemistry|June 7, 2021
Structural effects of meso-halogenation on porphyrinsKeith J Flanagan, Maximilian Paradiz Dominguez, Zoi Melissari, et al.
Advances in Therapy|May 4, 2023
Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative ReviewAmber N Edinoff, Natalie W Wu, Katelyn Parker, et al.
Journal of Inherited Metabolic Disease|April 24, 2009
The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell linesE R Benjamin, J J Flanagan, A Schilling, et al.
DNA Repair|December 10, 2024
Corrigendum to "BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination" [DNA Repair 115 (2022) 103331]Christopher Parker, Adam C Chambers, Dustin J Flanagan, et al.
DNA Repair|April 25, 2022
BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombinationChristopher Parker, Adam C Chambers, Dustin J Flanagan, et al.
Current Pain and Headache Reports|August 9, 2023
Cebranopadol for the Treatment of Chronic PainAmber N Edinoff, Chelsi J Flanagan, Logan T Roberts, et al.
Prehospital and Disaster Medicine|May 23, 2001
Telehealth and communication technologies in health: summary and action planS Braham, P Brownsword, H Delooz, et al.
Pageof 46

Showing results (401-410 of 459) with videos related to

Sort By:
Pageof 46
Journal of Endocrinological Investigation|March 9, 2024
Adipokine secretion and lipolysis following gender-affirming treatment in transgender individualsN Subramanian, A Wiik, E Rullman, et al.
Journal of Immunological Methods|November 17, 2009
Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonistT Wisniewski, E Bayne, J Flanagan, et al.
Human Mutation|May 21, 2011
A pharmacogenetic approach to identify mutant forms of α-galactosidase A that respond to a pharmacological chaperone for Fabry diseaseXiaoyang Wu, Evan Katz, Maria Cecilia Della Valle, et al.
Beilstein Journal of Organic Chemistry|June 7, 2021
Structural effects of meso-halogenation on porphyrinsKeith J Flanagan, Maximilian Paradiz Dominguez, Zoi Melissari, et al.
Advances in Therapy|May 4, 2023
Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative ReviewAmber N Edinoff, Natalie W Wu, Katelyn Parker, et al.
Journal of Inherited Metabolic Disease|April 24, 2009
The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell linesE R Benjamin, J J Flanagan, A Schilling, et al.
DNA Repair|December 10, 2024
Corrigendum to "BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination" [DNA Repair 115 (2022) 103331]Christopher Parker, Adam C Chambers, Dustin J Flanagan, et al.
DNA Repair|April 25, 2022
BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombinationChristopher Parker, Adam C Chambers, Dustin J Flanagan, et al.
Current Pain and Headache Reports|August 9, 2023
Cebranopadol for the Treatment of Chronic PainAmber N Edinoff, Chelsi J Flanagan, Logan T Roberts, et al.
Prehospital and Disaster Medicine|May 23, 2001
Telehealth and communication technologies in health: summary and action planS Braham, P Brownsword, H Delooz, et al.
Pageof 46